These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4971885)

  • 41. Purification and characterization of a hemolysin produced by Vibrio cholerae biotype El Tor: another toxic substance produced by cholera vibrios.
    Honda T; Finkelstein RA
    Infect Immun; 1979 Dec; 26(3):1020-7. PubMed ID: 118926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Snake venom toxins. The purification and amino acid sequence of toxin TA2 from Dendroaspis angusticeps venom.
    Viljoen CC; Botes DP
    J Biol Chem; 1974 Jan; 249(2):366-72. PubMed ID: 4203470
    [No Abstract]   [Full Text] [Related]  

  • 43. Structural elements of anaphylatoxin obtained by contact activation of hog serum.
    Liefländer M; Dielenberg D; Schmidt G; Vogi W
    Hoppe Seylers Z Physiol Chem; 1972 Mar; 353(3):385-92. PubMed ID: 5028204
    [No Abstract]   [Full Text] [Related]  

  • 44. Purification and characterization of an extracellular secretogenic non-membrane-damaging cytotoxin produced by clinical strains of Vibrio cholerae non-O1.
    Saha PK; Koley H; Nair GB
    Infect Immun; 1996 Aug; 64(8):3101-8. PubMed ID: 8757840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile.
    Banno Y; Kobayashi T; Kono H; Watanabe K; Ueno K; Nozawa Y
    Rev Infect Dis; 1984; 6 Suppl 1():S11-20. PubMed ID: 6426016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization and purification of cholera toxin.
    Heckly RJ; Wolochow H
    J Infect Dis; 1970 May; 121():Suppl 121:80+. PubMed ID: 5421431
    [No Abstract]   [Full Text] [Related]  

  • 47. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates.
    Singh DV; Matte MH; Matte GR; Jiang S; Sabeena F; Shukla BN; Sanyal SC; Huq A; Colwell RR
    Appl Environ Microbiol; 2001 Feb; 67(2):910-21. PubMed ID: 11157262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Snake venom toxins the amino acid sequences of two toxins from Ophiophagus hannah (King cobra) venom.
    Joubert FJ
    Biochim Biophys Acta; 1973 Jul; 317(1):85-98. PubMed ID: 4198767
    [No Abstract]   [Full Text] [Related]  

  • 49. Attempt to characterize choleragenic fraction and the skin permeability factor from vibrio culture filtrates as separate indentity.
    Chatterjee PK; Rao SS; Dutta NK
    Indian J Med Res; 1972 Nov; 60(11):1568-74. PubMed ID: 4654627
    [No Abstract]   [Full Text] [Related]  

  • 50. Snake venom toxins. Purification and properties of three toxins from Naja nivea (Linnaeus) (Cape cobra) venom and the amino acid sequence of toxin delta.
    Botes DP; Strydom DJ; Anderson CG; Christensen PA
    J Biol Chem; 1971 May; 246(10):3132-9. PubMed ID: 4995745
    [No Abstract]   [Full Text] [Related]  

  • 51. [XXII. On seed proteins. Toxin and agglutinin from Ricinus: purification and composition].
    Waldschmidt-Leitz E; Keller L
    Hoppe Seylers Z Physiol Chem; 1970 Aug; 351(8):990-4. PubMed ID: 5451287
    [No Abstract]   [Full Text] [Related]  

  • 52. Purification of Clostridium perfringens type C theta toxin.
    Hauschild AH; Lecroisey A; Alouf JE
    Can J Microbiol; 1973 Aug; 19(8):881-5. PubMed ID: 4356555
    [No Abstract]   [Full Text] [Related]  

  • 53. [The effects of cholerogen and isolated cellular components of V. cholerae].
    Zykin LF; Lobanov VN; Sageeva OF; Petrova LS
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Sep; 47(9):36-43. PubMed ID: 5519104
    [No Abstract]   [Full Text] [Related]  

  • 54. Purification and characterization of novel toxin produced by Vibrio cholerae O1.
    Walia K; Ghosh S; Singh H; Nair GB; Ghosh A; Sahni G; Vohra H; Ganguly NK
    Infect Immun; 1999 Oct; 67(10):5215-22. PubMed ID: 10496898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elapid neurotoxins. Purification, characterization, and immunochemical studies of -bungarotoxin.
    Clark DG; Macmurchie DD; Elliott E; Wolcott RG; Landel AM; Raftery MA
    Biochemistry; 1972 Apr; 11(9):1663-8. PubMed ID: 5028110
    [No Abstract]   [Full Text] [Related]  

  • 56. Purification and some properties of staphylococcal alpha-toxin.
    Watanabe M; Kato I
    Jpn J Exp Med; 1974 Apr; 44(2):165-78. PubMed ID: 4546168
    [No Abstract]   [Full Text] [Related]  

  • 57. Purification of phospholipase C (alpha-toxin) from Clostridium perfringens.
    Möllby R; Wadström T
    Biochim Biophys Acta; 1973 Oct; 321(2):569-84. PubMed ID: 4357667
    [No Abstract]   [Full Text] [Related]  

  • 58. Toxin(s), other than cholera toxin, produced by environmental non O1 non O139 Vibrio cholerae.
    Begum K; Ahsan CR; Ansaruzzaman M; Dutta DK; Ahmad QS; Talukder KA
    Cell Mol Immunol; 2006 Apr; 3(2):115-21. PubMed ID: 16696898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Homogeneity and molecular weight of toxin of Clostridium botulinum type B.
    Boroff DA; Dasgupta BR; Fleck US
    J Bacteriol; 1968 May; 95(5):1738-44. PubMed ID: 4967772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside.
    Tayot JL; Holmgren J; Svennerholm L; Lindblad M; Tardy M
    Eur J Biochem; 1981 Jan; 113(2):249-58. PubMed ID: 6258916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.